Publications

9 peer-reviewed papers from the group.

2026

Biotinylated Diaryl Isoxazole Derivatives with Enhanced Janus Kinase 1 Inhibitory, Antiproliferative, and Apoptotic Activities in Cancer Cells
Erguven et al.
ACS Omega · 2026
DOI PubMed

PI3K Signaling at the Crossroads of Lipid Metabolism and Cancer
Yilmaz & Cizmecioglu
Advances in Experimental Medicine and Biology · 2025
DOI PubMed

Molecular mechanisms of PI3K isoform dependence in embryonic growth
Atıcı & Çizmecioğlu
Journal of the Turkish-German Gynecological Association · 2024
DOI PubMed
Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt
Çatalak Yılmaz et al.
Turkish Journal of Biochemistry · 2024
DOI

Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers
Kaysudu et al.
Cancer Science · 2023
DOI PubMed
Rafting on the Plasma Membrane: Lipid Rafts in Signaling and Disease
Isik & Cizmecioglu
Advances in Experimental Medicine and Biology · 2023
DOI PubMed

Blocking PI3K p110β attenuates development of PTEN-deficient castration-resistant prostate cancer
Gao et al.
Molecular Cancer Research · 2022
DOI PubMed
ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK-STAT3 Pathway
Demir & Cizmecioglu
Cancer Diagnosis & Prognosis · 2022
DOI PubMed
p110alpha activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle
Cizmecioglu
Turkish Journal of Biology · 2022
DOI